Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ZAI Lab
Pharma
FDA signs off on Innoviva's Xacduro for bacterial pneumonia
Innoviva subsidiary Entasis has captured an FDA approval for Xacduro, a treatment for two types of hospital-acquired bacterial pneumonia.
Kevin Dunleavy
May 24, 2023 10:25am
Eisai, Astellas and Samsung Biologics—Fierce Pharma Asia
Jan 13, 2023 7:45am
Enhertu, Hutchmed, BeiGene-Novartis—Fierce Pharma Asia
Aug 12, 2022 9:50am
Eisai-Biogen, US delisting, Zai Lab and more
Mar 18, 2022 9:10am
SEC tags BeiGene, Hutchmed, Zai Lab for potential delisting
Mar 11, 2022 10:32am
BeiGene, Takeda, Zai Lab and more—Fierce Pharma Asia
Aug 6, 2021 5:54am